Journal of International Oncology ›› 2020, Vol. 47 ›› Issue (5): 257-263.doi: 10.3760/cma.j.cn371439-20191114-00015
• Original Articles • Next Articles
Yang Chao1,2(), Wang Jianbo1, Zhang Juhong1, Wang Jialong1
Received:
2019-11-14
Revised:
2020-03-12
Online:
2020-05-08
Published:
2020-07-02
Contact:
Yang Chao
E-mail:15618630875yc@sina.com
Yang Chao, Wang Jianbo, Zhang Juhong, Wang Jialong. Overexpression of miR-125 inhibits proliferation and invasion of nasopharyngeal carcinoma cells by down-regulating FGF-2[J]. Journal of International Oncology, 2020, 47(5): 257-263.
[1] |
Westra WH, Lewis JS Jr. Update from the 4th edition of the World Health Organization Classification of Head and Neck Tumours: Oropharynx[J]. Head Neck Pathol, 2017,11(1):41-47. DOI: 10.1007/s12105-017-0793-2.
doi: 10.1007/s12105-017-0793-2 pmid: 28247229 |
[2] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI: 10.3322/caac.21492.
doi: 10.3322/caac.21492 pmid: 30207593 |
[3] | Farazi TA, Hoell JI, Morozov P, et al. microRNAs in human cancer[J]. Adv Exp Med Biol, 2013,774(2):1-20. DOI: 10.1007/978-94-007-5590-1_17. |
[4] |
Zhu X, Li W, Zhang R, et al. MicroRNA-342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1[J]. Oncol Lett, 2018,16:1298-1304. DOI: 10.3892/ol.2018.8788.
doi: 10.3892/ol.2018.8788 pmid: 30061949 |
[5] |
Cheng JZ, Chen JJ, Wang ZG, et al. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-beta1/mTOR axis and HOXC6 in nasopharyngeal carcinoma[J]. Cancer Biomark, 2018,23(1):107-123. DOI: 10.3233/CBM-181459.
doi: 10.3233/CBM-181459 pmid: 29991129 |
[6] |
Zhang Y, Xu Z. MiR-93 enhances cell proliferation by directly targeting CDKN1A in nasopharyngeal carcinoma[J]. Oncol Lett, 2018,15(2):1723-1727. DOI: 10.3892/ol.2017.7492.
doi: 10.3892/ol.2017.7492 pmid: 29434867 |
[7] |
Wu W, Chen X, Yu S, et al. MicroRNA-222 promotes tumor growth and confers radioresistance in nasopharyngeal carcinoma by targeting PTEN[J]. Mol Med Rep, 2018,17(1):1305-1310. DOI: 10.3892/mmr.2017.7931.
doi: 10.3892/mmr.2017.7931 pmid: 29115464 |
[8] |
Huang P, Mao LF, Zhang ZP, et al. Down-regulated miR-125a-5p promotes the reprogramming of glucose metabolism and cell malignancy by increasing levels of CD147 in thyroid cancer[J]. Thyroid, 2018,28(5):613-623. DOI: 10.1089/thy.2017.0401.
doi: 10.1089/thy.2017.0401 pmid: 29634399 |
[9] |
Natalia MA, Alejandro GT, Virginia TJ, et al. MARK1 is a novel target for miR-125a-5p: implications for cell migration in cervical tumor cells[J]. Microrna, 2018,7(1):54-61. DOI: 10.2174/2211536606666171024160244.
doi: 10.2174/2211536606666171024160244 pmid: 29076440 |
[10] | 付西峰, 董秀山, 高飞, 等. 成纤维生长因子2在胰腺癌中的表达及对胰腺癌细胞侵袭与转移的作用和机制[J]. 山西医科大学学报, 2017,48(5):26-31. DOI: 10.13753/j.issn.1007-6611.2017.05.005. |
[11] |
Hou L, Pei L, Ma Y, et al. MicroRNA-125a-3p downregulation correlates with tumorigenesis and poor prognosis in patients with non-small cell lung cancer[J]. Oncol Lett, 2017,14(4):4441-4448. DOI: 10.3892/ol.2017.6809.
doi: 10.3892/ol.2017.6809 pmid: 29085440 |
[12] |
Huang X, Zhang T, Li G, et al. Regulation of miR-125a expression by rs12976445 single-nucleotide polymorphism is associated with radiotherapy-induced pneumonitis in lung carcinoma patients[J]. J Cell Biochem, 2019,120(3):4485. DOI: 10.1002/jcb.27736.
doi: 10.1002/jcb.27736 pmid: 30302847 |
[13] |
Jin L, Zhang Z, Li Y, et al. MiR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis[J]. Oncol Lett, 2017,13(6):4512-4520. DOI: 10.3892/ol.2017.5985.
doi: 10.3892/ol.2017.5985 pmid: 28599452 |
[14] |
Zhao A, Zeng Q, Xie X, et al. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression[J]. J Genet Genomics, 2012,39(1):29-35. DOI: 10.1016/j.jgg.2011.12.003.
doi: 10.1016/j.jgg.2011.12.003 |
[15] |
Zhang L, Yu H, Badzio A, et al. Fibroblast growth factor receptor 1 and related ligands in small-cell lung cancer[J]. J Thorac Oncol, 2015,10(7):1083-1090. DOI: 10.1097/JTO.000000000000-0562.
doi: 10.1097/JTO.0000000000000562 pmid: 26020126 |
[16] |
Sharpe R, Pearson A, Herrera-Abreu MT, et al. FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo[J]. Clin Cancer Res, 2011,17(16):5275-5286. DOI: 10.1158/0008-5472.SABCS10-P5-02-01.
doi: 10.1158/1078-0432.CCR-10-2727 pmid: 21712446 |
[1] | Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[2] | Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[3] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[4] | Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118. |
[5] | Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying. Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2023, 50(8): 475-483. |
[6] | Gu Anqin, Long Jinhua, Jin Feng. Clinical research progress of immunotherapy for nasopharyngeal carcinoma [J]. Journal of International Oncology, 2023, 50(5): 299-303. |
[7] | Yang Lirong, Wang Yufeng. Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer [J]. Journal of International Oncology, 2023, 50(4): 220-226. |
[8] | Ma Peihan, Zhang Lingming, Lu Ning, Zhang Mingxin. Effect of anesthesia on the recurrence and metastasis of hepatocellular carcinoma [J]. Journal of International Oncology, 2023, 50(2): 117-121. |
[9] | Zhao Jianhao, Duan Yanchao. Research progress in the pathogenesis of extramedullary disease in multiple myeloma [J]. Journal of International Oncology, 2023, 50(1): 55-59. |
[10] | Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou. Advances in immunotherapy for recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2022, 49(9): 517-520. |
[11] | Peng Chen, Xie Yintong, Zhang Xin, Xie Peng. Research progress of maintenance therapy for cervical cancer [J]. Journal of International Oncology, 2022, 49(7): 430-435. |
[12] | Chen Fangming, Cai Yuanyuan, Li Han, Wang Xiaoli, Kan Hongxing, Li Yang, Hao Furong, Wang Mingchen. Prognostic differences of nasopharyngeal carcinoma patients treated with intensity-modulated radiothe-rapy with different T staging of the seventh and eighth edition of the UICC staging system [J]. Journal of International Oncology, 2021, 48(9): 515-522. |
[13] | Wang Bin, Zhou Jiangyun, Liu Xi. Analysis of the clinical value of different radiotherapy schemes in patients with advanced esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2021, 48(8): 484-488. |
[14] | Peng Ya, Liu An, Liu Huowang. Inhibitory effect and mechanism of PSD-007 photodynamic therapy on human nasopharyngeal carcinoma transplanted tumors in nude mice [J]. Journal of International Oncology, 2021, 48(3): 136-142. |
[15] | Zhu Lei, Huang Jianbo. Effects of Epstein-Barr virus DNA load and different treatment methods on the therapeutic effect and prognosis of stage Ⅲ nasopharyngeal carcinoma [J]. Journal of International Oncology, 2021, 48(2): 74-79. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||